Search for: "PHARMACEUTICAL IP HOLDINGS, INC."
Results 61 - 80
of 168
Sort by Relevance
|
Sort by Date
22 Feb 2012, 4:40 am
bit.ly/yRWkxa (Henry Kelston) How to Create an eDiscovery Team – An Interview with HB Gordan from Teva Pharmaceuticals – bit.ly/xCM6yj (Amber Scorah) How to Reduce Medical Malpractice eDiscovery Issues and Costs - bit.ly/ylZmA5 (Matthew Keris) Innovation and Informed Risk-Taking are an eDiscovery Duty - bit.ly/zKtiDm (Chris Dale) Lester v. [read post]
30 Sep 2011, 3:14 am
[Link] IPMI is holding the IP Law & Management Institute on November 6th – 8th at the Rancho Las Palmas in Palm Springs, CA. [read post]
7 Sep 2011, 4:22 am
(Kluwer Patent Blog) Fortical (Calcitonin-salmon) – US: Obviousness in chemical formulations: (unclaimed) purpose of limitation leads to nonobviousness holding: Unigene Labs. and Upsher-Smith Labs v. [read post]
24 Aug 2011, 12:33 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
1 Aug 2011, 7:40 am
IP Watch brings news of an accord between the European Union and India on that most sensitive of topics, the manner and extent to which EU customs authorities can stop the passage of generic pharmaceutical products on their somewhat indirect route from where they're made to where they are intended or supposed to be sold. [read post]
1 Aug 2011, 6:03 am
Patent Docs‘ Kevin Noonan talks about the latest case in which the Federal Circuit assessed the scope of foreseeability for rebutting prosecution history estoppel, Duramed Pharmaceuticals, Inc. v. [read post]
29 Jul 2011, 11:13 pm
(Patent Docs) Cenestin (Synthetic conjugated estrogens) – US: CAFC: Prosecution history estoppel bars Duramed’s allegations of infringement under doctrine of equivalents: Duramed Pharmaceuticals, Inc. v. [read post]
30 Jun 2011, 3:38 am
Patent Jobs: Salix Pharmaceuticals is searching for an IP and Licensing Attorney with at least 3 years of experience in pharmaceutical patent prosecution. [read post]
15 Jun 2011, 4:56 am
Par Pharmaceutical, Inc. [read post]
10 Jun 2011, 1:40 pm
To some extent, we may have to assume that the general principles derived from intellectual property (“IP”) cases still hold in cases where IP rights are not at issue, and we cannot completely eliminate the risk that a court would conclude that the same principles do not apply. [read post]
9 Mar 2011, 3:00 am
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
3 Mar 2011, 10:13 am
The '065 patent is currently the subject of a litigation styled Firepass IP Holdings, Inc. et al. v. [read post]
3 Mar 2011, 10:13 am
The '065 patent is currently the subject of a litigation styled Firepass IP Holdings, Inc. et al. v. [read post]
2 Feb 2011, 10:32 am
IPS reported, "Lethal Drug Shortage Creates Ethical Quagmire," by Matthew Cardinale. [read post]
25 Jan 2011, 9:27 am
" Hold on a sec. [read post]
24 Jan 2011, 9:56 pm
Vice President Bret Parker (Elizabeth Arden, Inc.) will be leading this group in 2011. [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
22 Dec 2010, 3:01 am
Holdings v. [read post]
1 Dec 2010, 11:02 am
(Forensic investigator) Fresenius Medical Care Holdings, Inc. v. [read post]
16 Oct 2010, 1:50 pm
IP Holdings, LLC v. [read post]
